Daratumumab in Treating Participants With Relapsed Multiple Myeloma After Stem Cell Transplant

Clinical trial NCT03622775 · TERMINATED

Trial details

NCT number: NCT03622775
Sponsor: M.D. Anderson Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Plasma Cell Myeloma

Start date: 2019-04-11
Primary completion: 2025-10-09
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.